Dhaka, June 2 -- Growth Formula: The Billion-Dollar Prescription

From labs to exports: The sector has evolved from a basic manufacturing base into a powerhouse for low-cost generic medicines

Global breakthrough: Local drugmakers have entered strict US and EU markets, expanding their footprint across more than 150 nations.

Raw material gap: Crucial export gains are capped by a reliance on imported APIs, making domestic supply the next big hurdle

Milestone in sight: Sustained demand puts a first-ever $250 million annual export target within immediate reach for the sector

Bangladesh has continued to earn more foreign currency from pharmaceutical exports, with receipts approaching $195 million in the first 10 months of the ongoing fiscal...